1-8 of 8
Jian Yu, MD
Close
Sort by
Journal Articles

Salvage Therapy with Low-Dose Ruxolitinib Led to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients with cGvHD after Allogeneic Hematopoietic Stem Cell Transplantation

He Huang, MD PhD, Yanmin Zhao, MD, Guifang Ouyang, Jimin Shi, MD, Yi Luo, MD, Yamin Tan, MD, Jian Yu, MD, Huarui Fu, MD, Xiaoyu Lai, MD, Lizhen Liu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-141546
Published: 2020
Journal Articles

Ruxolitinib for Steroid-Refractory cGvHD: A Significant Response in Heavily Pretreated Patients after Haploidentical-SCT

Hengwei Wu, MD, Jimin Shi, MD, Yi Luo, MD, Yamin Tan, MD, Mingming Zhang, MD, Xiaoyu Lai, MD, Jian Yu, MD, Lizhen Liu, MD, Huarui Fu, MD, He Huang, MD PhD, Yanmin Zhao, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-141561
Published: 2020
Journal Articles

Maintenance Sorafenib Is Superior to Prophylactic DLI in Improving the Prognosis of FLT3-ITD-Positive AML after Allogeneic HSCT

Jimin Shi, MD, Liqin Cao, MD, Yi Luo, MD, Yanmin Zhao, MD, Yamin Tan, MD, Jian Yu, MD, Xiaoyu Lai, MD, Yuanyuan Zhu, MD, Yongxian Hu, MD, Jingsong He, MD, Jie Sun, MD, Weiyan Zheng, MD, Guoqing Wei, MD, He Huang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2668.
https://doi.org/10.1182/blood-2019-127594
Published: 2019
Journal Articles

The Effect of Continuous Screening of Carbapenem-Resistant Enterobacteriaceae on Theprevention and Control of Bloodstream Infections in Patients with Hematopoietic Stemcell Transplantation

Tingting Yang, Xueping Luo, MD, Qing Yang, MD, Hongchao Chen, Yi Luo, MD, Yanmin Zhao, MD, Xiaoyu Lai, MD, Jian Yu, MD, Yamin Tan, MD, Guoqing Wei, MD, He Huang, Jimin Shi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5606.
https://doi.org/10.1182/blood-2019-127599
Published: 2019
Journal Articles

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Yanmin Zhao, MD, Jimin Shi, MD, Xiaoqing Li, Yi Luo, MD, Yamin Tan, MD, Xiaoyu Lai, PhD, Jian Yu, MD, Jianping Lan, PhD, Wanmao Ni, PhD, Lieguang Chen, MD, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4561.
https://doi.org/10.1182/blood-2018-99-118649
Published: 2018
Journal Articles

Comparison of Chimeric Antigen Receptor T Cells from Allogenic or Autologous Sources in Patients with Acute Lymphoblastic Leukemia

Yongxian Hu, MD PhD, Jiasheng Wang, MD, Yanlei Zhang, Guoqing Wei, MD, Huijun Xu, Wenjun Wu, MD, Jian Yu, MD, Yi Luo, MD, Jimin Shi, MD, Shaohui Liu, Kangyan Wang, Zhenxing Guo, Alex HONGSHENG Chang, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2691.
https://doi.org/10.1182/blood-2018-99-117910
Published: 2018
Journal Articles

Outcome and Risk Factors of Transplantation-Associated Active Tuberculosis in Allogeneic Haematopoietic Stem Cell Transplantation: A Nested Case Control Study

Yanmin Zhao, MD, Apeng Yang, MD, Jimin Shi, MD, Yi Luo, MD, Xiaoyu Lai, PhD, Yamin Tan, MD, Jian Yu, MD, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3427.
https://doi.org/10.1182/blood-2018-99-119027
Published: 2018
Journal Articles

Chimeric Antigen Receptor T-Cell Therapy Shapes T Cell Repertoire in Chinese Patients with B-Cell Acute Lymphocyte Leukemia

Xiujian Wang, Tao Sun, PhD, Yongxian Hu, MD PhD, Xiao Liu, PhD, Jian Yu, MD, Pengfei Xu, Guoqing Wei, MD, Chao Jin, Wenjun Wu, MD, Fu Huarui, MD, Lijuan Ding, Fang Ni, Hao Zhang, Zuyu Liang, Binsheng Wang, PhD, Xiaoqing Li, Cong Wei, Yunyun Deng, MS, Jimin Shi, MD, Lei Xiao, PhD, Zhao Wu, PhD, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1413.
https://doi.org/10.1182/blood-2018-99-115780
Published: 2018